Group 1 - The core viewpoint of the news is that the Kexin Innovation Drug ETF (589720) has seen a net inflow of over 770 million yuan for 10 consecutive days, indicating strong capital interest and potential price improvements for the product [1] - The raw material drug sector has experienced a price decline over the past 4-5 years, with most API product prices at historical lows, but there is an expectation of price recovery due to rising commodity and upstream chemical prices [1] - The commercialization of GLP-1 drugs is generating significant global demand for APIs and intermediates, while several small nucleic acid chronic disease drugs are entering a harvest phase, providing opportunities for raw material companies to expand into CDMO services [1] Group 2 - The Kexin Innovation Drug ETF (589720) tracks the Kexin Innovation Drug Index (950161), which has a daily price fluctuation limit of 20%, focusing on new drug development driven by technological innovation [1] - The index includes companies in the biopharmaceutical and chemical pharmaceutical sectors that have high R&D investment and innovation capabilities, reflecting the overall trend of innovation development in China's pharmaceutical industry [1] - The ETF's investment strategy emphasizes growth style, targeting companies with significant potential in the innovative drug sector [1]

（文章来源：每日经济新闻） 碳中和50ETF国泰（159861）跟踪的是环保50指数（930614），该指数从中国A股市场中选取与环境保 护相关的领先企业，涵盖清洁能源、污染防治、资源循环利用等行业，以反映绿色经济领域内具有代表 性的公司表现。指数样本强调环境友好型技术和可持续发展策略的应用，通常具备良好的成长性和较高 的社会责任感。 国泰海通证券指出，数据中心光储配套与太空光伏有望成为新一轮设备扩产的重要催化因素。算力需求 提升推动数据中心对稳定、低成本、可复制的光伏+储能方案需求加速增长，地面光伏装机逻辑从电力 驱动逐渐转向算力驱动。同时，低轨卫星与太空算力发展带动太空光伏进入产业化验证阶段，对高效 率、轻薄柔性等提出更高要求，打开高端制造及定制化设备增量空间。随着SpaceX申请部署百万颗卫 星以构建轨道AI数据中心网络，光伏作为太空场景的重要能源供给方式，有望在轨道数据中心建设过 程中获得更多应用机会，相关光伏设备厂商将持续受益。 ...

（文章来源：每日经济新闻） 平安证券指出，波动率加速抬升背景下，金价短期或仍将呈现宽幅震荡走势。但长期来看，美国债务问 题未解，美元信用走弱的主线未现拐点，黄金长期走势难言见顶。短期企稳后，金价中枢或仍将抬升。 海外宏观不确定性持续，中期黄金避险属性仍处于放大阶段。长期来看特朗普上任后，美元信用走弱的 主线逻辑愈加清晰，黄金货币属性加速凸显，持续看好黄金中长期走势。 中长期看，黄金价格中枢仍有望上行，投资者或可考虑后续回调参与、逢低分批布局。关注直接投资实 物黄金，免征增值税的黄金ETF国泰（518800），覆盖黄金全产业链股票的黄金股票ETF（517400）。 ...

Group 1 - The core viewpoint is that China's API (Active Pharmaceutical Ingredient) exports are expected to remain relatively stable in total volume by 2025, despite trade changes and price competition, reflecting the industry's competitiveness [1] - In 2026, uncertainties in API trade will persist, with further competition and cooperation between China and India [1] - New technologies, such as synthetic biology, are driving down unit costs and enhancing the global competitiveness of Chinese companies in terms of quality and service efficiency [1] Group 2 - Some API prices have already bottomed out, and the trend of supply clearing is expected to continue, potentially leading to a price rebound due to changes in the competitive landscape and capacity utilization rates [1] - China's innovative pharmaceutical sector is anticipated to see a strong start in 2026, with several significant licensing deals validating technological capabilities [1] - The clinical data in the small nucleic acid drug field continues to validate its potential, accelerating market progress and attracting more leading companies to invest, which may drive the development of the supporting industrial chain [1] Group 3 - In the GLP-1 (Glucagon-like peptide-1) sector, a new pricing system is forming domestically, with rapid growth in overseas oral formulations [1] - Oral autoimmune drugs are also showing significant value [1] - The Guotai Innovation Drug ETF (589720) tracks the Innovation Drug Index (950161), which focuses on new drug development driven by technological innovation, reflecting the overall trend of innovation in China's pharmaceutical industry [1]

黄金大幅回调，资金持续布局，资金面看，黄金ETF国泰（518800）近20日资金净流入超76亿元。 平安证券指出，黄金价格冲高回落，呈现宽幅震荡走势。波动率加速抬升背景下，金价短期或仍将呈现 宽幅震荡走势。但长期来看，美国债务问题未解，美元信用走弱的主线未现拐点，黄金长期走势难言见 顶。短期企稳后，金价中枢或仍将抬升。海外宏观不确定性持续，中期黄金避险属性仍处于放大阶段。 长期来看特朗普上任后，美元信用走弱的主线逻辑愈加清晰，黄金货币属性加速凸显，持续看好黄金中 长期走势。 中长期看，黄金价格中枢仍有望上行，投资者或可考虑后续回调参与、逢低分批布局。关注直接投资实 物黄金，免征增值税的黄金ETF国泰（518800），覆盖黄金全产业链股票的黄金股票ETF（517400）。 （文章来源：每日经济新闻） ...

Group 1 - The commodity concept LOF experienced a significant decline across the board on February 2, with multiple funds hitting the limit down [1] - Specific funds such as Guotou Resources LOF, Resource LOF, and Southern Crude Oil LOF all faced limit down situations, indicating a severe downturn in the sector [1] - Guotai Commodity LOF dropped over 8%, while both Harvest Crude Oil LOF and Huabao Oil and Gas LOF fell more than 7%, reflecting a broader negative trend in commodity-related investments [1]

Core Viewpoint - The launch of the Hang Seng Gold ETF (code: 03170.HK) marks a significant development in the Hong Kong market, being the first physical gold ETF that allows direct redemption of physical gold through banks, thus bridging the gap between "paper gold" and physical gold [1][12]. Group 1: Product Overview - The Hang Seng Gold ETF was officially listed on January 29, 2026, with an initial price of HKD 16 per unit and a minimum investment threshold of approximately HKD 800 [3]. - On its first trading day, the ETF experienced a 9% increase, closing at HKD 17.44 [1][3]. - The ETF's structure allows for a seamless connection between ETF shares and physical gold, addressing a gap in the Hong Kong market [1][12]. Group 2: Market Context - As of January 14, 2026, the total scale of domestic gold-related ETFs reached CNY 262.86 billion, with the Huaan Gold ETF alone surpassing CNY 100.76 billion, reflecting a growth of over 67% since 2025 [2]. - The World Gold Council reported that by the end of 2024, the global gold ETF assets under management are expected to reach USD 274 billion, setting a new historical record [2][3]. Group 3: Redemption Mechanism - The Hang Seng Gold ETF offers equal redemption rights for both individual and institutional investors, allowing them to choose between cash or physical gold upon redemption [12]. - In contrast, mainland China's gold ETFs have a tiered redemption system, where individual investors can only sell ETF shares for cash, while institutional investors face minimum redemption thresholds [12]. Group 4: Strategic Developments - Recent initiatives in Hong Kong's gold market include signing cooperation agreements with the Shanghai Gold Exchange and plans to enhance gold storage capacity to 2,000 tons within three years, aiming to improve the entire gold trading ecosystem [13].

Group 1 - The advanced packaging and testing industry for integrated circuits is experiencing rapid expansion, with the global market expected to grow from $101.47 billion in 2024 to $134.9 billion by 2029, driven by advanced packaging's share increasing from 40% to 50% [1] - The fastest-growing technology segment is chip-scale integration packaging, projected to have a compound annual growth rate (CAGR) of 25.8% [1] - The explosive growth of the digital economy and artificial intelligence is a key growth driver, with global computing power expected to rise from 2207 EFLOPS in 2024 to 14130 EFLOPS by 2029, reflecting a CAGR of 45% [1] Group 2 - In the consumer electronics sector, the accelerated penetration of high-end and AI smartphones is driving demand for advanced packaging technologies such as WLCSP and FO [1] - China's integrated circuit industry still has a low self-sufficiency rate, indicating significant potential for substitution [1] - The Guotai AI ETF (589110) tracks the Sci-Tech AI Index (950180), which includes 30 large-cap listed companies in the AI sector, reflecting the overall performance of representative AI-related stocks in the Sci-Tech Innovation Board [1]

（文章来源：每日经济新闻） 国信证券指出，AI浪潮驱动下，科技成长依然是本轮牛市的行业主线，行情有望从硬件向应用端扩 散。近期AI应用端催化频现：政策层面，1月初工信部等印发《"人工智能+制造"专项行动实施意 见》，明确以推动信息化和工业化深度融合为主线，推动AI在工业领域落地。产业层面，去年末蚂蚁 集团推出医疗健康AI应用"阿福"，目前月活用户已达3000万。借鉴15年和21年牛市经验，本轮科技行情 有望从算力基建向应用扩散。 1月30日，科技主线反弹，科创200ETF国泰（589220）涨超1%，AI浪潮下，把握科技成长行业主线。 科创200ETF国泰（589220）跟踪的是科创200指数（000699），单日涨跌幅限制达20%，该指数从科创 板中选取市值较大、流动性较好的200只证券作为指数样本，覆盖了新一代信息技术、生物医药、新材 料、新能源等多个高新技术产业和战略性新兴产业，以反映科创板中代表性上市公司证券的整体表现。 ...

Core Viewpoint - The humanoid robot industry is transitioning from "0 to 1" to "1 to 10," with significant changes in downstream orders expected by 2025, exemplified by UBTECH's humanoid robot orders nearing 1.4 billion yuan [1] Group 1: Industry Developments - Elon Musk announced that Tesla will sell humanoid robots to the public by the end of 2027 [1] - Yushui announced that its actual shipment of humanoid robots will exceed 5,500 units by 2025 [1] - The sector is entering a spring rally period, with a focus on the landing time of Tesla's Optimus V3 orders in 2026 and the application landing of domestic manufacturers [1] Group 2: Supply Chain and Market Opportunities - The supply chain for large models, actuators, reducers, lead screws, and force sensors is expected to benefit from these developments [1] - The liquid cooling sector is anticipated to grow due to increased AI capital expenditure and rising data center power consumption, with a market space projected to reach hundreds of billions by 2030 [1] Group 3: Investment Products - The Guotai (159388) ETF tracks the ChiNext AI Index (970070), with a daily price fluctuation limit of 20% [1] - The index selects listed companies involved in machine learning, big data analysis, and other AI technologies from the ChiNext market to reflect the overall performance of AI-related securities [1] - The index components focus on high growth and innovation characteristics, with an emphasis on information technology and high-end manufacturing sectors, aiming to reflect the development trends of China's emerging technology industry [1]